Ocugen Financials - Benzinga

Ocugen Inc

OCGNNASDAQ

Trade with Public

Trade with Public

$1.02

0.022%

À la clôture: Sep 25, 5:00 PM EST

$1.03

0.010.98%

Après les heures: 5:38 PM EST

Aperçu Actualités Prévisions de résultats Événements Objectifs de coursDonnées financièresSentiment Actionnariat Comparer Options Rapport sur les stocks

Ocugen Financials

Ocugen (OCGN) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Ocugen Q2 EPS $(0.07) Misses $(0.05) Estimate, Sales $1.488M Beat $888.833K Estimate

Ocugen (NASDAQ:OCGN) reported quarterly losses of $(0.07) per share which missed the analyst consensus estimate of $(0.05) by 40 percent. This is a 40 percent decrease over losses of $(0.05) per share from the same

Benzinga Newsdesk

PRO
Ocugen Q1 EPS $(0.06) Misses $(0.05) Estimate, Sales $1.533M Beat $540.000K Estimate

Ocugen (NASDAQ:OCGN) reported quarterly losses of $(0.06) per share which missed the analyst consensus estimate of $(0.05) by 20 percent. This is a 20 percent decrease over losses of $(0.05) per share from the same

Benzinga Newsdesk

Earnings Scheduled For May 5, 2026

Benzinga Insights

Earnings Summary: Ocugen Q4

Benzinga Insights

PRO
Ocugen Q4 EPS $(0.06), Inline, Sales $(193.000K) Miss $860.000K Estimate

Ocugen (NASDAQ:OCGN) reported quarterly losses of $(0.06) per share which met the analyst consensus estimate. This is a 20 percent decrease over losses of $(0.05) per share from the same period last year. The company

Benzinga Newsdesk

Earnings Scheduled For March 4, 2026

Benzinga Insights

© 2026 Benzinga | All Rights Reserved